Australia & New Zealand

Cannabix Secures First Distributor Order for BreathLogix Alcohol Screening Devices in Australia

Cannabix has developed an autonomous alcohol breathalyser screening device for employers and a range of industries and safety settings...

AI Model Offers Breakthrough Path for Early Diagnosis and Novel Cancer Targets

Dr Cifuentes Bernal explains how his AI-powered framework uncovers hidden cancer-associated genes...

UniSA Scientists Develop AI Tool to Map Gene Interactions Fueling Tumour Growth

The researchers showed that the AI-driven system not only detects well-known cancer genes but also uncovers previously hidden ones...

Redefining Scalp Health in Australia

Key Pharmaceuticals and Alliance Pharma are working to redefine scalp health as a core part of overall wellbeing...

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data...

Pharmacists at the Forefront as Alliance Pharma and Key Pharmaceuticals Mark Five Years of Nizoral Partnership

Key Pharmaceuticals and Alliance Pharma are championing pharmacists as key players in reframing scalp health as an essential part of overall wellness...

New Zealand’s Wellumio Launches Equity Crowdfunding To Revolutionise Stroke Care With Portable Brain Scanner

Medtech firm unveils Axana®, a 50kg, AI-enhanced, portable MRI device that cuts stroke diagnosis time by over 90%—unlocking lifesaving treatment in the golden hour and opening an $8.9bn global market opportunity....

Orthocell’s Remplir Enters Urology with Use in Robotic Prostate Surgeries

Orthocell is collating clinical data on initial patients who underwent radical prostatectomies with Remplir in Australia and will release the clinical data once available...

Alpha Global partners with LIO to redefine Mental Health Care in Australia

New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals ...

ELIXIR MD Expands into Australia and New Zealand with Exclusive Launch of Breakthrough Facial Surgery Device

In partnership with High Tech Medical Pty Ltd., ELIXIR MD brings its proprietary ELIXIR MD™ device and advanced perioperative protocols to one of the world’s fastest-growing aesthetic surgery markets, redefining post-operative care and patient recovery outcomes. ...